Listed

Dianthus Therapeutics, Inc.: Form 8-K/A, filed Sep 21, 2023

Filed with the SEC on Sep 21, 2023 and accepted by EDGAR at Sep 20, 2023, 21:50 ET.

Share

Items reported

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001193125-23-238850. Last ingested by Listed: Nov 13, 2026, 16:49 ET. Listed shows no prices and gives no investment advice.